Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel B Walter

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
Vaccine|December 11, 2025
Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.
Vaccine|June 25, 2011
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adultsRobert W Frenck, Robert Belshe, Rebecca C Brady, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2006
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USAMichael D Green, Bernard Beall, Mario J Marcon, et al.
Clinical Pharmacokinetics|December 16, 2024
Population Pharmacokinetics of Meropenem Across the Adult LifespanAngelique E Boutzoukas, Stephen J Balevic, Marion Hemmersbach-Miller, et al.
Annals of Epidemiology|April 30, 2024
Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023Adam Z Blatt, Mina Suh, Emmanuel B Walter, et al.
JAMA Network Open|November 6, 2024
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical TrialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.
Communications Biology|December 31, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Influenza and Other Respiratory Viruses|May 16, 2024
Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID-19: Results From Four Health Systems, 2015-2023Adam Z Blatt, Mina Suh, Emmanuel B Walter, et al.
Pediatrics|January 30, 2016
Safety and Immunogenicity of Sequential Rotavirus Vaccine SchedulesRomina Libster, Monica McNeal, Emmanuel B Walter, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Vaccine|December 11, 2025
Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.
Vaccine|June 25, 2011
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adultsRobert W Frenck, Robert Belshe, Rebecca C Brady, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2006
Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USAMichael D Green, Bernard Beall, Mario J Marcon, et al.
Clinical Pharmacokinetics|December 16, 2024
Population Pharmacokinetics of Meropenem Across the Adult LifespanAngelique E Boutzoukas, Stephen J Balevic, Marion Hemmersbach-Miller, et al.
Annals of Epidemiology|April 30, 2024
Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023Adam Z Blatt, Mina Suh, Emmanuel B Walter, et al.
JAMA Network Open|November 6, 2024
Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical TrialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.
Communications Biology|December 31, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
A neutralizing human antibody induces movement of the HCoV-229E receptor binding domainMera F Liccione, Trevor Scobey, Heather M Froggatt, et al.
Influenza and Other Respiratory Viruses|May 16, 2024
Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID-19: Results From Four Health Systems, 2015-2023Adam Z Blatt, Mina Suh, Emmanuel B Walter, et al.
Pediatrics|January 30, 2016
Safety and Immunogenicity of Sequential Rotavirus Vaccine SchedulesRomina Libster, Monica McNeal, Emmanuel B Walter, et al.
Pageof 14